GlaxoSmithkline Consumer Healthcare has informed that a meeting of the Board of Directors of the company will be held on November 06, 2013 to consider and take on record the Unaudited Financial Results for the quarter ended on September 30, 2013 with Limited Review done by the Statutory Auditors.
The above information is a part of company’s filings submitted to BSE.